3.0
Oct 4, 2014
Current employee, more than 10 years
Waltham, MA
Recommend
CEO approval
Business Outlook
Pros
Excellent science Good colleagues Good work life balance The CEO Soriot is slowly turning the ship around
Cons
Middle management not in touch with levels above or below Slow decision making Cutting staff and research sites year on year Exiting major disease areas year on year Medimmune acquisition not paying off Horrible IT system for scientists